Discover an altogether different kind of CDMO
Partner with creative scientists and problem-solvers dedicated to making your drug development journey a success.
For over 40 years, our experts at Pfizer CenterOne have been listening, solving, and guiding our partners’ drug projects to success.
But what makes us an altogether different kind of CDMO?
A surprisingly refreshing approach to collaboration
Our open and collaborative approach to drug development means we can offer you true transparency across every stage of development as we are on a continuous mission to deliver on what we promise.
A solid foundation to get drug products to market
For over four decades, we have walked in the shoes of drug developers just like you and understand the challenges you face. Learning about your unique needs and ambitions and driving projects like yours on the path to success is what has made us the trusted CDMO partner of choice for customers all over the world.
Draw upon the scientific power of Pfizer
Integrated within a brand name synonymous with success, we strive to bring you the time and dedication of a small-scale CDMO, as well as the resources and expertise of Pfizer.
Manufacturing that scales to any size
By bringing you the capabilities of a global manufacturing network, we can scale with you across every step of your drug manufacturing journey. No goal is too ambitious, and we’re by your side to help you get from where you are now to wherever you want your drug product to be.
A culture of confidentiality where IP remains uncompromised
IP protection is key for any drug development project, which is why we are guided by a culture of confidentiality to ensure your secrets are always safe with us.
Our Environmental, Health and Safety Commitment
Partner with a CDMO that shares your commitment to protecting the environment and our communities around the world. We’re always exploring new ways to minimise our impact on the environment in our mission to develop life-changing medicines for your patients.

Related News
-
Sponsored Content CPHI Podcast Series: Key Considerations in Selecting the Right CMO Partner
In this month's episode we hear from Jayna Blake, Senior Project Manager for Technical Programs at Baxter BioPharma Solutions, on key considerations for successful CMO selection. -
Sponsored Content PharmaNutra announces new technology to combat iron deficiency
This oral solution allows for high iron absorption while minimising digestive issues -
Sponsored Content Size doesn’t matter: How smaller deals are shaping healthcare M&A
Several mega-deals have made a splash in the pharma and life sciences industries over recent years – from AstraZeneca’s acquisition of Alexion for $39 billion to Gilead Sciences’ $21 billion purchase of Immunomedics. With am... -
Sponsored Content Rise in home-based healthcare shaping pharma packaging and drug delivery
The pharma packaging and drug delivery industry has long been synonymous with rapid innovation. As medicine advances and patient needs change, so too should drug packaging and devices. This has been particularly evident during the pandem... -
Sponsored Content Biologics earmarked as opportunity in pharma packaging and drug delivery
The pharma packaging and drug delivery industry has gone through many evolutions, most notably to meet the challenges posed by the COVID-19 pandemic over the last two years. Disruptions to global supply chains posed a major issue, combined with a sharp... -
Sponsored Content Sustainability and digital adoption among trends shaping pharma packaging and drug delivery
The pharma packaging and drug device industry is constantly evolving to optimise drug delivery, keep up with medical advances and ensure regulatory compliance. Trends like sustainability, cost-efficiency and digitisation continue to shape the sector, a... -
Sponsored Content Croda: Solutions for Your High Value Drug Products
Formulating a drug for parenteral delivery comes with its fair set of challenges. Aside from a high level of sensitivity to external factors like light and heat exposure, these large and complex drugs are prone to degradation when exposed to various ch... -
Sponsored Content Audits in the time of COVID-19 – Implications for a CMO
Travel restrictions imposed by the pandemic have limited the ability of pharmaceutical companies and health authority personnel to travel and conduct in-person inspections of contract manufacturing organizations (CMOs). Due to t...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance